A pilot characterization of human lung NSCLC by protein pathway activation mapping.
Dissecting the Dual Role of AMPK in Cancer: From Experimental to Human Studies.
Biomarkers in the accurate subclassification of non-small-cell lung carcinoma for targeted therapy: issues and prospects.
Precision oncology based on omics data: The NCT Heidelberg experience.
Impact of upfront cellular enrichment by laser capture microdissection on protein and phosphoprotein drug target signaling activation measurements in human lung cancer: Implications for personalized medicine.
Signaling pathway profiling by reverse-phase protein array for personalized cancer medicine.
Advances towards the design and development of personalized non-small-cell lung cancer drug therapy.